cola lipid c efficacy against albicans Candida accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2α signaling CO2 enhances the formation, nutrient
CO2 enhances the formation, nutrient scavenging and drug resistance properties of C. albicans biofilms npj Biofilms and Microbiomes The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo Scientific Reports Antifungal Efficacy of Antimicrobial Peptide Octominin II against Candida albicans Nanostructured Lipid Carrier Based on Melaleuca Alternifolia and Bacuri Butter Associated with the Subdose of Amphotericin B: Cytotoxic and Antimicrobial Activity BioNanoScience Springer Nature Link
Pay in 4 interest-free payments of $7.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



